Publication | Closed Access
Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study
182
Citations
23
References
2020
Year
MedicinePathologyCancer TreatmentNeuroendocrine TumorsOncologyRadiation OncologyCancer ResearchEndocrine-related Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1